ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0495

Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients

Yelitza Cecilia Velarde Mejia1, Manuel Ugarte-Gil2, Risto Perich3, Cesar Pastor4, Graciela Alarcon5 and RV, Gamboa-Cardenas6, 1Hncase, Arequipa, Peru, 2Universidad Cientifica del Sur, Lima, Lima, Peru, 3Hospital Almenara, Lima, Peru, 4UNMSM, LIMA, Peru, 5The University of Alabama at Birmingham, Oakland, CA, 6Universidad Científica del Sur, Lima, Lima, Peru

Meeting: ACR Convergence 2024

Keywords: Biomarkers, functional status, Health Assessment Questionnaire (HAQ), rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The triglyceride/glucose index (TGI) is a metabolic marker associated with insulin resistance and cardiovascular risk. In patients with Rheumatoid Arthritis (RA), chronic inflammation and prolonged use of glucocorticoids can contribute to metabolic disturbances, including dyslipidemia and dysglycemia. Therefore, the TGI could provide an integrated view of the metabolic status of patients with RA and potentially correlate with functional capacity. Our aim was to evaluate the association between the TGI and functional capacity, as assessed by the Health Assessment Questionnaire (HAQ), in patients with RA.

Methods: This was a cross-sectional analysis of an established RA cohort constituted by patients referred to a Peruvian tertiary care center (the Almenara RA cohort). Patients are being followed every six months with a standard protocol that includes an interview, medical records review, physical examination (including 28 joint counts), and laboratory tests that included fasting glucose and triglycerides. For the present study, we included patients who had a visit between March 2014 and December 2017

For categorical variables, frequencies and percentages were obtained whereas for continuous variables medians and interquartile ranges (IQR) were. A normality test of Kolmogorov-Smirnov was performed. To evaluate the association between TGI with the HAQ [the modified HAQ (mHAQ), the functional HAQ (fnHAQ) and the psychological HAQ (pHAQ)], univariable linear regression models were used. Subsequently, a multivariable linear regression model, adjusted for gender, age, socioeconomic status, tobacco use, disease duration, ACPA (Anti–citrullinated protein antibodies) levels, disease activity (Disease Activity Score-28 with C reactive protein [DAS-28 CRP]), treatment (average dose of glucocorticoids over the last 3 months, cs- DMARDs and b-DMARDs use) and the Charlson comorbidity index.

Results: Two hundred and forty-seven patients were included. The average (SD) age was 63.0 (12.8) years, disease duration was 8.45(1.26) years; nearly all the patients were Mestizo (99.6%) and 229 (92.7%) were women. In the univariable analysis, a higher TGI was associated with higher pHAQ with B=0.73 (p˂0.01) no significant correlation was found with either the mHAQ or the fnHAQ. In the corresponding multivariable analysis, this correlation remained significant with B=0.80 (p˂0.01). The univariable and multivariable analyses are shown in Table 1.

Conclusion: The study demonstrated a significant association between TGI and pHAQ in patients with RA. This finding highlights the potential role of metabolic dysregulation in contributing to psychological distress in RA patients. Further research is warranted to explore the mechanisms underlying the observed associations and to evaluate whether interventions targeting metabolic factors in RA patients could improve psychological outcomes.

Supporting image 1


Disclosures: Y. Velarde Mejia: None; M. Ugarte-Gil: AstraZeneca, 1, 6, Ferrer, 1, GlaxoSmithKlein(GSK), 6, Janssen, 5, Tecnofarma, 2, 6, 12, Travel Support; R. Perich: None; C. Pastor: None; G. Alarcon: None; R. Gamboa-Cardenas: None.

To cite this abstract in AMA style:

Velarde Mejia Y, Ugarte-Gil M, Perich R, Pastor C, Alarcon G, Gamboa-Cardenas R. Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/correlation-between-triglyceride-glucose-index-and-functional-capacity-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-triglyceride-glucose-index-and-functional-capacity-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology